2014 annual financial data
Neuphoria Therapeutics 2014 Operating cash flow margin
Direct answer
Operating cash flow margin was -71.65%.
Operating income was -3,563,110 USD and net income was 3,019,014 USD.
Operating cash flow was -12,913,213 USD.
Get free Neuphoria Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 18,022,167 USD
- Operating income
- -3,563,110 USD
- Net income
- 3,019,014 USD
- Operating cash flow
- -12,913,213 USD